Labiana posts revenues of over €39 million in the first half of 2025, up 11.7% year-on-year

Labiana posts strong H1 2025 results with €7.4M adjusted EBITDA, up 12.8%, driven by growth in animal and human health divisions.

MADRID, MADRID, SPAIN, October 31, 2025 /⁨EINPresswire.com⁩/ — Labiana, the Spanish pharmaceutical group dedicated to the …